Both in Electromedical Equipment
ENDRA Life Sciences vs Hyperfine
Over the past year NDRA returned −10.1% and HYPR returned −36.2%; their daily moves had a correlation of -0.13.
NDRA −10.1% HYPR −36.2%Growth of $1, one year, split-adjusted
| Metric | NDRA | HYPR |
|---|---|---|
| Price | $4.74 | $0.7846 |
| Market cap | $7.1M | $83.2M |
| Today | −4.45% | +4.66% |
| 1 month | −19.4% | −2.5% |
| 6 months | −2.3% | −45.5% |
| Year to date | +4.6% | −19.9% |
| 1 year | −10.6% | −37.2% |
| Revenue growth (YoY) | — | +44.8% |
| Gross margin | — | 50.7% |
| Net margin | — | −238.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 5.0× |
| Net cash | $1.7M | $30.2M |
| Dividend yield | — | — |
| Volatility (60d) | 86.3% | 48.0% |
| Short % of float | 1.7% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).